top of page

    1. 2:31

       

      Dr. Nicholas Vogelzang Discusses Latest Advances in Prostate Cancer - Duration: 2:31.

      OncLiveTV

      Nicholas J. Vogelzang, MD, medical oncologist, US Oncology Research and Comprehensive Cancer Centers Nevada, 2015 ...

      • Play next

      • Play now

      • 1 year ago

      • 183 views

    2. 1:53

       

      Dr. Nicholas Vogelzang Discusses Sequencing Abiraterone and Enzalutamide - Duration: 1:53.

      OncLiveTV

      Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

      • Play next

      • Play now

      • 4 years ago

      • 669 views

    3. 1:50

       

      Dr. Nicholas Vogelzang Discusses Radium-223 in Prostate Cancer - Duration: 1:50.

      OncLiveTV

      Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

      • Play next

      • Play now

      • 4 years ago

      • 558 views

    4. 2:55

       

      Dr. Nicholas Vogelzang Discusses PSMA ADC in Prostate Cancer - Duration: 2:55.

      Targeted Oncology

      Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

      • Play next

      • Play now

      • 4 years ago

      • 597 views

    5. 0:53

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, on the practice-changing results of the LATITUDE study - Duration: 0:53.

      OBRoncology

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, comments on how the results ...

      • Play next

      • Play now

      • 3 months ago

      • 13 views

    6. 1:00

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, on identifying the best patients for Zytiga versus Xtandi - Duration: 1:00.

      OBRoncology

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, describes how to identify the ...

      • Play next

      • Play now

      • 3 months ago

      • 39 views

    7. 15:42

       

      What to do with the post-abiraterone/-enzalutamide patient? - Nicholas J. Vogelzang - Duration: 15:42.

      Summit on Genitourinary Cancers

      • Play next

      • Play now

      • 1 year ago

      • 305 views

    8. 1:34

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, discusses the influence of an AR-V7 commercial test - Duration: 1:34.

      OBRoncology

      Nicholas J. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, on the impact a ...

      • Play next

      • Play now

      • 6 months ago

      • 27 views

    9. 3:03

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, on immunotherapy and metastatic prostate cancer - Duration: 3:03.

      OBRoncology

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, offers feedback on if ...

      • Play next

      • Play now

      • 6 months ago

      • 54 views

    10. 8:35

       

      ASCO 2013 - Nicholas Vogelzang, MD, discusses Xofigo (radium Ra 223 dichloride) - Duration: 8:35.

      Oncology.TV

      At the ASCO 2013 Meeting, Nicholas Vogelzang, MD, of the Comprehensive Cancer Centers of Nevada discusses the recent FDA ...

      • Play next

      • Play now

      • 4 years ago

      • 807 views

    11. 1:41

       

      Nicholas J. Vogelzang, MD, on where chemotherapy fits into treatment for prostate cancer - Duration: 1:41.

      OBRoncology

      Dr. Vogelzang, Medical Oncologist, Comprehensive Cancer Centers of Nevada, on where chemotherapy fits into treatment for ...

      • Play next

      • Play now

      • 6 months ago

      • 29 views

    12. 1:47

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, discusses resistance and advanced prostate cancer - Duration: 1:47.

      OBRoncology

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, explains how the treatment ...

      • Play next

      • Play now

      • 6 months ago

      • 43 views

    13. 1:09

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, on treating metastatic prostate cancer with multiple drugs - Duration: 1:09.

      OBRoncology

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, shares his thoughts on how ...

      • Play next

      • Play now

      • 6 months ago

      • 23 views

    14. 0:48

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, speculates on the cost implications of abiraterone - Duration: 0:48.

      OBRoncology

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, elaborates on the cost ...

      • Play next

      • Play now

      • 3 months ago

      • No views

    15. 1:31

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, discusses the potential of the AR-V7 test - Duration: 1:31.

      OBRoncology

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, considers the AR-V7 test and ...

      • Play next

      • Play now

      • 3 months ago

      • 6 views

    16. 2:09

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, considers data from CHAARTED, STAMPEDE, and LATTITUDE - Duration: 2:09.

      OBRoncology

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, offers perspective on ...

      • Play next

      • Play now

      • 3 months ago

      • 14 views

    17. 1:25

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, on metastatic castration-resistant prostate cancer patients - Duration: 1:25.

      OBRoncology

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, explains which metastatic ...

      • Play next

      • Play now

      • 6 months ago

      • 43 views

    18. 1:14

       

      Dr. Vogelzang Describes Cabozantinib's Side Effects - Duration: 1:14.

      OncLiveTV

      Nicholas J. Vogelzang, MD, from the Comprehensive Cancer Centers of Nevada describes cabozantinib's side effects.

      • Play next

      • Play now

      • 6 years ago

      • 744 views

    19. 1:19

       

      Dr. Nicholas Vogelzang on First-Line Axitinib Versus Sorafenib in mRCC - Duration: 1:19.

      OncLiveTV

      Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

      • Play next

      • Play now

      • 4 years ago

      • 58 vie

        • 2 years ago

        • 10,420 views

  2. What is Targeted Therapy, with Nicholas Vogelzang, MD - Duration: 6:33.

    Cancer.Net

    What is Targeted Therapy, with Nicholas Vogelzang, MD​​

  1. About 712 results

    Upload date

    Type

    Duration

    Features

    Sort by

    1. 1:14

      • Play next

      • Play now

       

      Dr. Vogelzang Describes Cabozantinib's Side Effects - Duration: 1:14.

      OncLiveTV

      • 6 years ago

      • 744 views

      Nicholas J. Vogelzang, MD, from the Comprehensive Cancer Centers of Nevada describes cabozantinib's side effects.

    2. 1:36

      • Play next

      • Play now

       

      Dr. Vogelzang Discusses Mortalities in Cabozantinib Trial - Duration: 1:36.

      OncLiveTV

      • 6 years ago

      • 820 views

      Nicholas J. Vogelzang, MD, Comprehensive Cancer Centers of Nevada Discusses Mortalities in Cabozantinib Trial.

    3. 0:56

      • Play next

      • Play now

       

      Dr. Vogelzang on Cabozantinib Clinical Trial Results - Duration: 0:56.

      OncLiveTV

      • 6 years ago

      • 294 views

      Nicholas J. Vogelzang, MD, from the Comprehensive Cancer Centers of Nevada on the Cabozantinib Clinical Trial Results.

    4. 4:06

      • Play next

      • Play now

       

      SIR 2016: Robert L. Vogelzang accepts SIR Gold Medal - Duration: 4:06.

      Society of Interventional Radiology (SIR)

      • 1 year ago

      • 182 views

      A past president of the Society of Interventional Radiology (SIR), Robert Vogelzang has served as chief of vascular and ...

    5. 6:11

      • Play next

      • Play now

       

      Perspectives in Prostate Cancer - Dr. Nick Vogelzang ASCO 2014 - Duration: 6:11.

      Oncology.TV

      • 3 years ago

      • 97 views

      From ASCO 2014, Dr. Nick Vogelzang discusses Abstract 5011: Inhibition of PD-L1 by MPDL3280A and clinical activity in pts with ...

    6. 1:11

      • Play next

      • Play now

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, on BRCA1 and BRCA2 genetic testing as guidelines - Duration: 1:11.

      OBRoncology

      • 6 months ago

      • 20 views

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, weighs in on if genetic ...

    7. 1:42

      • Play next

      • Play now

       

      Nicholas J. Vogelzang, MD, FASCO, FACP, explains the influence of CHAARTED and STAMPEDE - Duration: 1:42.

      OBRoncology

      • 6 months ago

      • 15 views

      Dr. Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, discusses how CHAARTED ...

    8. 8:41

      • Play next

      • Play now

       

      Nicholas Vogelzang on the Top Cancer Breakthroughs of 2011 - Duration: 8:41.

      GoodNewsBroadcast

      • 5 years ago

      • 49 views

      The American Society of Clinical Oncology (ASCO) is releasing their annual report on the progress against cancer.

    9. 3:28

      • Play next

      • Play now

       

      Mesothelioma Treatment Origins ~ Interview with Dr Vogelzang - Duration: 3:28.

      Smith Gat

      • 3 years ago

      • 16 views

      compensation mesothelioma find personal injury attorney houston injury attorney houston injury lawyer houston mesothelioma ...

    10. 3:24

      • Play next

      • Play now

       

      Mesothelioma Symptoms and Risk Factors with Dr. Vogelzang - Duration: 3:24.

      connellyvogelzang

      • 5 years ago

      • 288 views

      http://convoglaw.com/media-center/videos/ Dr. Vogelzang is a medical oncologist with 30 years of experience treating ...

    11. 0:52

      • Play next

      • Play now

       

      Dr. Vogelzang Discusses the Prostate Health Cocktail - Duration: 0:52.

      OncLiveTV

      • 4 years ago

      • 174 views

      Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

    12. 1:04

      • Play next

      • Play now

       

      Dr. Vogelzang Discusses Treatment With Radium-223 and Chemotherapy for Prostate Cancer - Duration: 1:04.

      Targeted Oncology

      • 4 years ago

      • 139 views

      Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

    13. 4:50

      • Play next

      • Play now

       

      Nicholas J. Vogelzang, M.D. - 2014 Inspired Excellence Award Recipient | Las Vegas HEALS - Duration: 4:50.

      Las Vegas HEALS

      • 2 years ago

      • 213 views

      Meet Nicholas J. Vogelzang, MD, one of the six recipients of the prestigious Inspired Excellence in Health Care Awards. Dr.

    14. 3:45

      • Play next

      • Play now

       

      Dr. Vogelzang Reviews Radium-223 in Metastatic Prostate Cancer - Duration: 3:45.

      Targeted Oncology

      • 4 years ago

      • 270 views

      Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

    15. 1:58

      • Play next

      • Play now

       

      Holiday Healthcare Happy Hour 2015 - Nicholas Vogelzang - Duration: 1:58.

      Las Vegas HEALS

      • 1 year ago

      • 35 views

      Become a member: http://www.lasvegasheals.org/join Las Vegas HEALS would like to thank all those who where attendance for ...

    16. 1:32

      • Play next

      • Play now

       

      Utility of PD-L1 as a Biomarker in Bladder Cancer - Duration: 1:32.

      OncLiveTV

      • 2 years ago

      • 155 views

      Nicholas J. Vogelzang, MD, discusses the utility of PD-L1 as a biomarker of response for PD-1/PD-L1 inhibitors in patients with ...

    17. 4:31

      • Play next

      • Play now

       

      Mesothelioma Clinical Trial: Interview with Dr. Vogelzang - Duration: 4:31.

      connellyvogelzang

      • 5 years ago

      • 129 views

      http://convoglaw.com/media-center/videos/ Dr. Vogelzang talks about the drugs that are available to mesothelioma patients as ...

    18. 3:07

      • Play next

      • Play now

       

      Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer - Duration: 3:07.

      OncLiveTV

      • 3 years ago

      • 283 views

      Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

    19. 1:11

      • Play next

      • Play now

       

      Dr. Vogelzang on XL184's Effect on Bone Metastases - Duration: 1:11.

      OncLiveTV

      • 6 years ago

      • 512 views

      Nicholas J. Vogelzang, MD, From the Comprehensive Cancer Centers of Nevada on Cabozantinib's (XL184) Effect on Bone ...

    20. 1:45

      • Play next

      • Play now

       

      Dr. Vogelzang Discusses Cabozantinib's Dose Size - Duration: 1:45.

    21. About 712 results

    22. Upload date

    23. Last hour

    24. Today

    25. This week

    26. This month

    27. This year

    28. Type

    29. Video

    30. Channel

    31. Playlist

    32. Movie

    33. Show

    34. Duration

    35. Short (< 4 minutes)

    36. Long (> 20 minutes)

    37. Features

    38. 4K

    39. HD

    40. Subtitles/CC

    41. Creative Commons

    42. 3D

    43. Live

    44. Purchased

    45. 360°

    46. Sort by

    47. Relevance

    48. Upload date

    49. View count

    50. Rating

    51. 3:07

    52.  

    53. Play next

    54. Play now

    55.  

    56. Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer - Duration: 3:07.

    57. OncLiveTV

    58. 3 years ago

    59. 283 views

    60. Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

    61. 1:45

    62.  

    63. Play next

    64. Play now

    65.  

    66. Dr. Vogelzang Discusses Cabozantinib's Dose Size - Duration: 1:45.

    67. OncLiveTV

    68. 6 years ago

    69. 290 views

    70. Nicholas J. Vogelzang, MD, from the Comprehensive Cancer Centers of Nevada discusses cabozantinib's dose size.

    71. 3:25

    72.  

    73. Play next

    74. Play now

    75.  

    76. Evolving Renal Cell Carcinoma Treatment Paradigm - Duration: 3:25.

    77. OncLiveTV

    78. 2 years ago

    79. 305 views

    80. Nicholas J. Vogelzang, MD, discusses the rapidly evolving treatment paradigm for patients with renal cell carcinoma, which ...

    81. 1:11

    82.  

    83. Play next

    84. Play now

    85.  

    86. Dr. Vogelzang on XL184's Effect on Bone Metastases - Duration: 1:11.

    87. OncLiveTV

    88. 6 years ago

    89. 512 views

    90. Nicholas J. Vogelzang, MD, From the Comprehensive Cancer Centers of Nevada on Cabozantinib's (XL184) Effect on Bone ...

    91. 0:47

    92.  

    93. Play next

    94. Play now

    95.  

    96. Dr. Vogelzang Describes Two Additional Analyses of the ALSYMPCA Trial - Duration: 0:47.

    97. OncLiveTV

    98. 4 years ago

    99. 32 views

    100. Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

    101. 1:34

    102.  

    103. Play next

    104. Play now

    105.  

    106. Dr. Vogelzang Discusses the Cabozantinib Trial Design - Duration: 1:34.

    107. OncLiveTV

    108. 6 years ago

    109. 222 views

    110. Nicholas J. Vogelzang, MD, head of the Genitourinary Cancer Section at the Comprehensive Cancer Centers of Nevada ...

    111. 1:21

    112.  

    113. Play next

    114. Play now

    115.  

    116. New diagnostics for prostate cancer - Duration: 1:21.

    117. vhsimons

    118. 7 years ago

    119. 270 views

    120. Dr. Nick Vogelzang talks about new tests to screen for prostate cancer.

    121. 1:12

    122.  

    123. Play next

    124. Play now

    125.  

    126. Dr. Vogelzang Discusses MPDL3280A in Patients with Metastatic Urothelial Bladder Cancer - Duration: 1:12.

    127. Targeted Oncology

    128. 3 years ago

    129. 218 views

    130. Nicholas J. Vogelzang, MD, member of the US Oncology Network, site research leader for Comprehensive Cancer Centers of ...

    131. 2:21

    132.  

    133. Play next

    134. Play now

    135.  

    136. CCCN Patient Profile: William - Duration: 2:21.

    137. Comprehensive Cancer Centers of Nevada

    138. 1 year ago

    139. 533 views

    140. William, a patient of Comprehensive Cancer Centers of Nevada, along with his physician, Dr. Nicholas Vogelzang, discusses his ...

    141. 3:00

    142.  

    143. Play next

    144. Play now

    145.  

    146. Mesothelioma Treatment: Interview with Dr. Vogelzang - Duration: 3:00.

    147. connellyvogelzang

    148. 5 years ago

    149. 171 views

    150. http://convoglaw.com/media-center/videos/ Dr. Vogelzang discusses different treatment options that are currently available to ...

    151. 2:31

    152.  

    153. Play next

    154. Play now

    155.  

    156. CCCN: Clinical Research - Duration: 2:31.

    157. Comprehensive Cancer Centers of Nevada

    158. 6 years ago

    159. 689 views

    160. Dr. Nicholas Vogelzang of Comprehensive Cancer Centers of Nevada (CCCN) explains the processes and benefits of clinical ...

    161. 1:44

    162.  

    163. Play next

    164. Play now

    165.  

    166. About Nicholas Vogelzang - Mesothelioma Attorney - Duration: 1:44.

    167. Vogelzang Law

    168. 1 year ago

    169. 114 views

    170. 5:35

    171.  

    172. Play next

    173. Play now

    174.  

    175. ASCO-GU Meeting Highlights - Duration: 5:35.

    176. MDedge

    177. 4 years ago

    178. 333 views

    179. The 2013 Genitourinary Cancers Symposium was more about expansion of knowledge than major practice changers.

    180. 2:54

    181.  

    182. Play next

    183. Play now

    184.  

    185. Mesothelioma Chemotherapy, Alternative Treatments, and Surgery: Interview with Dr. Vogelzang - Duration: 2:54.

    186. connellyvogelzang

    187. 5 years ago

    188. 123 views

    189. http://convoglaw.com/media-center/videos/ Dr. Vogelzang discusses chemotherapy versus surgery, or a combination of both as ...

    190. 2:02

    191.  

    192. Play next

    193. Play now

    194.  

    195. Dr. Vogelzang | 3rd Annual Inspired Excellence in Health Care Awards Gala | Las Vegas HEALS - Duration: 2:02.

    196. Las Vegas HEALS

    197. 2 years ago

    198. 57 views

    199. Las Vegas HEALS honored six local physicians for their outstanding contributions to the community as Las Vegas continues to ...

    200.  

    201. Vogelzang Law: Mesothelioma & Asbestos Attorneys - Channel

    202. 4 videos

    203. Nicholas Vogelzang is an Illinois -based mesothelioma and asbestos lawyer who has worked with families across the U.S. for ...

    204. Channel

    205. Loading...

    206. Unsubscribe from Vogelzang Law: Mesothelioma & Asbestos Attorneys?

    207. CancelUnsubscribe

    208. Working...

    209. SubscribeSubscribedUnsubscribe

    210. 5:05

    211.  

    212. Play next

    213. Play now

    214.  

    215. New data on Radium 223 presented at ASCO - Duration: 5:05.

    216. MDedge

    217. 4 years ago

    218. 851 views

    219. Dr. Nicholas Vogelzang, investigator on the ALSYMPCA trial, discusses new data on Radium 223 (Xofigo) and new research on ...

    220. 0:32

    221.  

    222. Play next

    223. Play now

    224.  

    225. Congrats Dr. Vogelzang | 3rd Annual Inspired Excellence in Health Care Awards Gala | Las Vegas HEALS - Duration: 0:32.

    226. Las Vegas HEALS

    227. 2 years ago

    228. 34 views

    229. Las Vegas HEALS honored six local physicians for their outstanding contributions to the community as Las Vegas continues to ...

    230. 10:06

    231.  

    232. Play next

    233. Play now

    234.  

    235. Prostate Cancer News from ASCO 2010 - Duration: 10:06.

    236. Vital Options International

    237. 7 years ago

    238. 94 views

    239. Nicholas J. Vogelzang, medical oncologist, Nevada Comprehensive Cancer Centers, discusses prostate cancer updates.

    240.  

    241. 60 videos

    242. Play all

    243.  

    244. Play now

    245.  

    246. Oncology - Playlist

  3. Play next

  4. Play now

  5.  

  6. Checkpoint Inhibitors Under Exploration in RCC - Duration: 2:06.

  7. OncLiveTV

  8. 2 years ago

  9. 38 views

  10. Nicholas J. Vogelzang, MD, describes several early phase clinical trials assessing PD-1 inhibitors for patients with renal cell 

    1. WorldNewsMD

    2. ​

​

bottom of page